跳至主要内容
临床试验/ISRCTN15634328
ISRCTN15634328已完成未知

COVID-19 antibody response in healthcare staff: Prevalence, duration and protection against recurring infection

Abbott (Germany)0 个研究点目标入组 2,000 人开始时间: 2020年8月13日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
2,000

研究概览

简要总结

2021 Results article in https://pubmed.ncbi.nlm.nih.gov/33987193/ 3-month follow-up results (added 28/01/2022)

研究设计

研究类型
Observational

入排标准

性别
All

入选标准

  • 1. Aged =18 years
  • 2. Agrees to complete all aspects of the study

排除标准

  • 1. Previously participated in this study on a previous occasion
  • 2. Unable or unwilling to provide informed consent
  • 3. Is a vulnerable person as deemed unfit for the study by the Principal Investigator
  • 4. Current symptoms of COVID-19 or has had COVID-19 symptoms within the last 14 days

研究者

发起方
Abbott (Germany)

相似试验